Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05951842Withdrawn
Randomised trial of propofol injection (veterinary) and sevoflurane in colorectal cancer (CRC) (2 arms), sponsored by Gangnam Severance Hospital. Primary endpoint: Postoperative immune function (NK cell count) at 1 day. Planned start Apr 2018; status: withdrawn.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05951842.